Lexicon Pharmaceutcl (LXRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 21,450 | 59,520 | 64,065 | 92,118 | 89,887 |
| Marketable Securities | 40,518 | 26,982 | 22,678 | 28,800 | 28,614 |
| Receivables | 34 | 37 | 14 | 23 | 159 |
| TOTAL | $64,898 | $88,431 | $88,921 | $124,005 | $123,258 |
| Non-Current Assets | |||||
| PPE Net | 1,035 | 1,142 | 1,176 | 1,311 | 1,201 |
| Intangibles | 44,543 | 44,543 | 44,543 | 44,543 | 44,543 |
| Other Non-Current Assets | 1,849 | 2,062 | 2,269 | 2,471 | 2,670 |
| TOTAL | $47,427 | $47,747 | $47,988 | $48,325 | $48,414 |
| Total Assets | $112,325 | $136,178 | $136,909 | $172,330 | $171,672 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | 11,693 | 11,675 |
| Accounts payable and accrued liabilities | 7,347 | 9,321 | 9,152 | 8,345 | 8,545 |
| Accrued Expenses | 9,515 | 9,584 | 12,972 | 14,208 | 12,595 |
| TOTAL | $16,862 | $18,905 | $22,124 | $34,246 | $32,815 |
| Non-Current Liabilities | |||||
| Long Term Debt | 23,631 | 23,477 | N/A | N/A | N/A |
| Other Non-Current Liabilities | 1,002 | 1,098 | 1,190 | 1,481 | 1,624 |
| TOTAL | $24,633 | $24,575 | $1,190 | $1,481 | $1,624 |
| Total Liabilities | $41,495 | $43,480 | $23,314 | $35,727 | $34,439 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 183,626 | 149,594 | 149,594 | 148,896 | 144,474 |
| Common Shares | 150 | 150 | 150 | 150 | 146 |
| Retained earnings | -1,535,839 | -1,511,252 | -1,487,776 | -1,462,165 | -1,439,043 |
| Other shareholders' equity | -211 | -98 | 472 | 476 | 477 |
| TOTAL | $70,830 | $92,698 | $113,595 | $136,603 | $137,233 |
| Total Liabilities And Equity | $112,325 | $136,178 | $136,909 | $172,330 | $171,672 |